Holen Sie sich die Stockscreener-App
20.60
1.93%
0.4257
Schlusskurs vom Vortag:
$20.17
Offen:
$20.41
24-Stunden-Volumen:
245.51K
Relative Volume:
0.68
Marktkapitalisierung:
$990.89M
Einnahmen:
$151.91M
Nettoeinkommen (Verlust:
$-46.03M
KGV:
-20.39
EPS:
-1.01
Netto-Cashflow:
$5.65M
1W Leistung:
-8.50%
1M Leistung:
-9.31%
6M Leistung:
-20.53%
1J Leistung:
-17.23%
1-Tages-Spanne:
$20.20
$21.01
1-Wochen-Bereich:
$19.55
$25.25
52-Wochen-Spanne:
$19.10
$29.62
Biolife Solutions Inc Stock (BLFS) Company Profile
Firmenname
Biolife Solutions Inc
Sektor
Telefon
(425) 401-1400
Adresse
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Compare BLFS vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
20.58 | 971.15M | 151.91M | -46.03M | 5.65M | -1.01 |
|
ISRG
Intuitive Surgical Inc
|
502.80 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.06 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
83.64 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.20 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
43.32 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2024-09-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-11 | Eingeleitet | Craig Hallum | Buy |
| 2022-04-25 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-10-19 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-05-14 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2021-03-23 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-18 | Eingeleitet | Cowen | Outperform |
| 2020-08-11 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-07-08 | Bestätigt | Maxim Group | Buy |
| 2020-02-24 | Eingeleitet | Lake Street | Buy |
| 2020-02-19 | Eingeleitet | The Benchmark Company | Buy |
| 2020-02-06 | Fortgesetzt | B. Riley FBR | Buy |
| 2020-01-08 | Eingeleitet | Stephens | Overweight |
| 2019-11-21 | Eingeleitet | Oppenheimer | Outperform |
| 2019-07-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-11-10 | Bestätigt | Maxim Group | Buy |
| 2017-09-19 | Bestätigt | Maxim Group | Buy |
| 2017-07-05 | Hochstufung | Janney | Neutral → Buy |
| 2017-03-10 | Bestätigt | Maxim Group | Buy |
| 2017-01-19 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Biolife Solutions Inc Aktie (BLFS) Neueste Nachrichten
BLFS SEC FilingsBiolife Solutions Inc 10-K, 10-Q, 8-K Forms - Stock Titan
BioLife Solutions (BLFS) -10%: Stock Drops on 'Sell the News' Reaction to Strong Guidance - Trefis
BioLife Solutions (NASDAQ:BLFS) Stock Price Down 11.2%Time to Sell? - MarketBeat
BioLife Solutions, Inc. (BLFS) Stock Analysis: 43.87% Potential Upside Captures Investor Attention - DirectorsTalk Interviews
BioLife Solutions, Inc. $BLFS Shares Sold by Royce & Associates LP - MarketBeat
BioLife Solutions Highlights Growth and Strategic Refocus in Presentation - TipRanks
BioLife Solutions issues investor presentation highlighting FY2025 results and 2026 guidance - TradingView
BioLife Solutions (BLFS) details 2025 surge and 2026 profit outlook - Stock Titan
Wall Street Analysts Believe BioLife Solutions (BLFS) Could Rally 35%: Here's is How to Trade - Finviz
Does BioLife’s 2026 Profitability Guidance and Media Strength Change The Bull Case For BLFS? - simplywall.st
Should BioLife Solutions’ 2026 Profitability Guidance and Refocus Require Action From BLFS Investors? - Yahoo Finance
BLFS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BLFS PE Ratio & Valuation, Is BLFS Overvalued - Intellectia AI
BioLife Solutions (NASDAQ:BLFS) Raised to Buy at Wall Street Zen - MarketBeat
BioLife Solutions (NASDAQ:BLFS) Shares Gap UpWhat's Next? - MarketBeat
Can BioLife Solutions Capitalize On The Explosive Growth Of The Cell And Gene Therapy Market? - RTTNews
BioLife Solutions (BLFS) Q4 Profitability Glimpse Tests Bullish Margin Narratives - Sahm
Beyond the Balance Sheet: What SWOT Reveals About BioLife Soluti - GuruFocus
BioLife Solutions Inc (BLFS) Q4 2025 Earnings Call Highlights: S - GuruFocus
BioLife Solutions, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
BioLife Solutions Inc reports results for the quarter ended September 30Earnings Summary - TradingView
BioLife Solutions (BLFS) director receives 8,170-share stock grant - Stock Titan
BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates - Nasdaq
BioLife Solutions (NASDAQ: BLFS) exec reports stock grant and tax withholding - Stock Titan
BioLife Solutions (NASDAQ: BLFS) CMO gets stock awards and tax withholding - Stock Titan
BioLife Solutions (BLFS) director awarded 8,170 restricted shares - Stock Titan
BioLife Solutions (BLFS) CFO receives 2026 stock grants - Stock Titan
Restricted stock grant to BioLife Solutions (BLFS) director Ellingson - Stock Titan
New stock awards and tax share withholdings for BioLife (BLFS) CEO - Stock Titan
BioLife Solutions (BLFS) HR chief awarded 23,548 shares - Stock Titan
BioLife Solutions (BLFS) CTO granted 24,116 restricted shares for 2026 pay - Stock Titan
[Form 4] BIOLIFE SOLUTIONS INC Insider Trading Activity - Stock Titan
BioLife Solutions (NASDAQ:BLFS) Posts Quarterly Earnings Results, Beats Estimates By $0.24 EPS - MarketBeat
BioLife Solutions (BLFS) awards 8,170 restricted shares to director - Stock Titan
BioLife Solutions Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: BioLife Solutions Q4 2025 earnings beat expectations - Investing.com
BioLife : Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations - marketscreener.com
BLFS Projects Significant Margin Expansion by 2026 - GuruFocus
BioLife Solutions (BLFS) Reports Strong Q4 Revenue and Anticipat - GuruFocus
BioLife Solutions Earnings Report: Q4 Overview - Benzinga
Earnings Flash (BLFS) BioLife Solutions, Inc. Reports Q4 Revenue $24.8M, vs. FactSet Est of $24.1M - marketscreener.com
[8-K] BIOLIFE SOLUTIONS INC Reports Material Event | BLFS SEC FilingForm 8-K - Stock Titan
BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations - StreetInsider
BioLife Solutions earnings on deck as profitability tested - Investing.com
BioLife Solutions Q4 2025 Earnings Call Transcript - MarketBeat
BioLife Solutions (BLFS) Expected to Announce Quarterly Earnings on Thursday - Defense World
What are analysts price targets for BioLife Solutions IncJuly 2025 Update & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Trading the Move, Not the Narrative: (BLFS) Edition - Stock Traders Daily
Swing Trade: Does VANI stock reflect fundamentals2025 Breakouts & Breakdowns & Consistent Return Strategy Ideas - baoquankhu1.vn
BioLife Solutions, Inc. (NASDAQ:BLFS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market - BioInformant
Finanzdaten der Biolife Solutions Inc-Aktie (BLFS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.26%
2.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):